Private equity firm Everstone Capital is set to sell its entire 11.26% stake in Restaurant Brands Asia Ltd, the operator of Burger King in India and Indonesia. The deal, valued at around $57 million, will bring in a new strategic investor the family office of Ajanta Pharma founders, expected to inject up to ₹800 crore.
In a significant development for India’s quick-service restaurant sector, Everstone Capital has decided to fully exit its investment in Restaurant Brands Asia Ltd (RBA), the franchisee of Burger King in India and Indonesia. The stake sale, amounting to 11.26%, is valued at approximately $57 million, according to Refinitiv data.
The company, listed in Mumbai with a market capitalization of $437 million, will welcome a new strategic investor. Reports suggest that the family office of Ajanta Pharma’s founders, which also operates restaurant chains such as Chinese Wok and Big Bowl under Lenexis FoodWorks, is poised to step in. The investor could infuse up to ₹800 crore into RBA, strengthening its financial position and growth prospects.
Key Highlights:
-
Seller: Everstone Capital, via QSR Asia Pte Ltd.
-
Stake Sold: Entire 11.26% holding in Restaurant Brands Asia.
-
Valuation: Around $57 million.
-
New Investor: Ajanta Pharma family office, with potential ₹800 crore infusion.
-
Market Cap: RBA valued at $437 million in Mumbai.
-
Strategic Impact: Marks Everstone’s complete exit and a fresh chapter for Burger King’s India and Indonesia operations.
This transition underscores the dynamic nature of India’s fast-food industry, with new capital expected to drive expansion and competitiveness in the Burger King franchise.
Sources: Moneycontrol, Business Standard, Hindustan Times, Economic Times.